Sat Mar 8 4:52PM - 13 days, 18 hours left in session
| Sponsors | ||
|---|---|---|
| Sen. Elizabeth "Liz" Stefanics | 39 | San Miguel, Santa Fe, Torrance & Valencia |
| Rep. Elizabeth "Liz" Thomson | 24 | Bernalillo |
| Sen. Martin Hickey | 20 | Bernalillo |
| Rep. Reena Szczepanski | 47 | Santa Fe |
| Status | |||
|---|---|---|---|
| SHPAC | [Referred, not scheduled] | ||
| STBTC | |||
This is the official nmlegis action history. I'm doing my best to translate the LONG/WEIRD-STRING to something less gibberishy. And before you ask, no, the "Legis Day" number has no mapping to the real world.
Actions: [2] SHPAC/STBTC-SHPAC
| Legis Day | Action | Details |
|---|---|---|
| 2 | referred | SHPAC/STBTC |
| 2 | sent | SHPAC |
This table shows bill actions detected on Ed's system, using heuristics that may not be 100% accurate and which may not reflect the "official" nmlegis chronology. It is probably more than you care to know.
| Jan 30 | filed: [Prefiled by Elizabeth "Liz" Stefanics et al; not yet on nmlegis] |
| [new] | |
| sent to SHPAC | |
| title: '[prefiled by Elizabeth "Liz" Stefanics Et Al; Not Yet on Nmlegis]' -> 'Add Classes to Prior Authorization Drugs' | |
| actions: 'SPREF' -> '[2] SHPAC/STBTC-SHPAC' | |
| new sponsor: Elizabeth "Liz" Stefanics | |
| new sponsor: Elizabeth "Liz" Thomson | |
| new sponsor: Martin Hickey | |
| Feb 10 | new sponsor: Reena Szczepanski |
SENATE BILL 207
57th legislature - STATE OF NEW MEXICO - first session, 2025
INTRODUCED BY
Elizabeth "Liz" Stefanics and Elizabeth "Liz" Thomson
and Martin Hickey and Reena Szczepanski
AN ACT
RELATING TO INSURANCE; AMENDING THE PRIOR AUTHORIZATION ACT TO ADD MORE CLASSES OF DRUGS THAT ARE NOT SUBJECT TO PRIOR AUTHORIZATIONS OR STEP THERAPY PROTOCOLS.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
SECTION 1. Section 59A-22B-8 NMSA 1978 (being Laws 2023, Chapter 114, Section 13, as amended) is amended to read:
"59A-22B-8. PRIOR AUTHORIZATION FOR PRESCRIPTION DRUGS OR STEP THERAPY FOR CERTAIN CONDITIONS PROHIBITED.--
A. Coverage for medication approved by the federal food and drug administration that is prescribed, for on-label or off-label use, for the treatment of an autoimmune disorder, cancer, a rare disease or a substance use disorder, pursuant to a medical necessity determination, shall not be subject to prior authorization, except in cases in which a biosimilar, interchangeable biologic or generic version is available.
B. A health insurer shall not impose step therapy requirements before authorizing coverage for medication approved by the federal food and drug administration that is prescribed, for on-label or off-label use, for the treatment of an autoimmune disorder, cancer, a rare disease or a substance use disorder, pursuant to a medical necessity determination, except in cases in which a biosimilar, interchangeable biologic or generic version is available.
C. For the purposes of this section, "rare disease" means a disease or medical condition that affects fewer than two hundred thousand people in the United States."
- 2 -